Prime Medicine, Inc.(PRME:US)
Market Cap$627.16M
Key Metrics
Price$3.47
Revenue (TTM)$4.07M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$187.89M
EBITDA (TTM)-$191.12M
Op. Margin (TTM)-4.82K%
Dividend Yield-
Holders Yield-
Cash on hand$47.45M
Total Assets$249.04M
Net Assets$39.81M
Total Debt$103.51M
Key Metrics
Price$3.47
Revenue (TTM)$4.07M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$187.89M
EBITDA (TTM)-$191.12M
Op. Margin (TTM)-4.82K%
Dividend Yield-
Holders Yield-
Cash on hand$47.45M
Total Assets$249.04M
Net Assets$39.81M
Total Debt$103.51M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.15M | $856K | $838K | $1.23M | $1.12M | $1.45M | $2.18M | $209K | $0 | $591K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $44.44M | $51.51M | $49.45M | $55.2M | $54.49M | $53.85M | $46.41M | $54.44M | $55.67M | $48.93M | $54.54M | $51.46M | $45.26M | $40.03M | $38.69M | $31.66M | $26.31M | $19.9M | $60.08M | $10.43M | $2.17M | |
| Research and Development | $33.4M | $34.11M | $34.71M | $43.99M | $41.38M | $40.56M | $34.1M | $40.34M | $43.07M | $37.77M | $41.46M | $40.97M | $34.6M | $30.88M | $29.06M | $25.05M | $18.94M | $13.68M | $52.89M | $7.4M | $920K |
| Selling, General, and Administrative | $11.04M | $17.41M | $14.74M | $11.21M | $13.12M | $13.28M | $12.3M | $14.1M | $12.6M | $11.16M | $13.08M | $10.49M | $10.66M | $9.15M | $9.63M | $6.61M | $7.37M | $6.22M | $7.19M | $3.03M | $1.25M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$43.29M | -$50.65M | -$48.61M | -$53.97M | -$53.38M | -$52.39M | -$44.22M | -$54.23M | -$55.67M | -$48.34M | -$54.54M | -$51.46M | -$45.26M | -$40.03M | -$38.69M | -$31.66M | -$26.31M | -$19.9M | -$60.08M | -$10.43M | -$2.17M |
| $1.18M | $1.53M | $2.53M | $3.39M | $786K | $502K | $1.95M | $1.71M | $211K | $2.71M | -$11.1M | $643K | $2.9M | $434K | -$783K | $2.52M | -$3.49M | -$4.47M | -$1.45M | -$8.36M | -$353K | |
| Non-Operating Interest Income | $788K | $1.02M | $1.08M | $1.14M | $743K | $1.18M | $1.54M | $697K | $611K | - | - | $410K | $635K | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | $388K | $511K | $1.45M | $2.25M | $43K | -$680K | $408K | $1.02M | -$400K | $2.71M | -$11.1M | $233K | $2.27M | $434K | -$783K | $2.52M | -$3.49M | -$4.47M | -$1.45M | -$8.36M | -$353K |
Income Before Tax | -$42.11M | -$49.12M | -$46.08M | -$50.58M | -$52.59M | -$51.89M | -$42.28M | -$52.52M | -$55.46M | -$45.63M | -$65.64M | -$50.82M | -$42.35M | -$39.6M | -$39.47M | -$29.14M | -$29.79M | -$24.37M | -$61.53M | -$18.78M | -$2.53M |
Income Tax | - | - | - | - | $0 | $0 | $0 | $0 | -$134K | $134K | $0 | -$108K | $31K | -$202K | -$186K | $212K | -$442K | -$532K | $1.38M | -$2.37M | $4K |
Net Income | -$42.11M | -$49.12M | -$46.08M | -$50.58M | -$52.59M | -$51.89M | -$42.28M | -$52.52M | -$55.33M | -$45.76M | -$65.64M | -$50.71M | -$42.39M | -$39.4M | -$39.28M | -$29.35M | -$29.35M | -$23.84M | -$62.91M | -$16.41M | -$2.53M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0 | $0 | - | - | -$1.47M | $0 | $0 |
Net Income to Common | -$42.11M | -$49.12M | -$46.08M | -$50.58M | -$52.59M | -$51.89M | -$42.28M | -$52.52M | -$55.33M | -$45.76M | -$65.64M | -$50.71M | -$42.39M | -$39.4M | -$39.28M | -$29.35M | -$29.35M | -$23.84M | -$61.44M | -$16.41M | -$2.53M |
Shares Outstanding (Basic) | 177.22M | 177.1M | - | 160.5M | 129.19M | 130.88M | - | 119.76M | 119.19M | 104.47M | - | 91.85M | 90.47M | 89.06M | 74.19M | 94.34M | 71.8M | 71.8M | - | 71.8M | 64.9M |
Shares Outstanding (Diluted) | 177.22M | 177.1M | - | 160.5M | 129.19M | 130.88M | - | 119.76M | 119.19M | 104.47M | - | 91.85M | 90.47M | 89.06M | 74.19M | 94.34M | 71.8M | 71.8M | - | 71.8M | 64.9M |
EPS (Basic) | -$0.24 | -$0.28 | - | -$0.32 | -$0.41 | -$0.40 | - | -$0.44 | -$0.46 | -$0.44 | - | -$0.55 | -$0.47 | -$0.44 | -$0.56 | -$0.38 | -$0.50 | -$0.42 | - | -$0.32 | -$0.039 |
EPS (Diluted) | -$0.24 | -$0.28 | - | -$0.32 | -$0.41 | -$0.40 | - | -$0.44 | -$0.46 | -$0.44 | - | -$0.55 | -$0.47 | -$0.44 | -$0.56 | -$0.38 | -$0.50 | -$0.42 | - | -$0.32 | -$0.039 |
EBIT | -$43.29M | -$50.65M | -$48.61M | -$53.97M | -$53.38M | -$52.39M | -$44.22M | -$54.23M | -$55.67M | -$48.34M | -$54.54M | -$51.46M | -$45.26M | -$40.03M | -$38.69M | -$31.66M | -$26.31M | -$19.9M | -$60.08M | -$10.43M | -$2.17M |
EBITDA | -$41.5M | -$48.8M | -$47.27M | -$53.55M | -$51.01M | -$49.64M | -$42.56M | -$52.89M | -$52.21M | -$48.19M | -$40.43M | -$48.65M | -$44.4M | -$37.28M | -$36.11M | -$32.81M | -$22.15M | -$15.12M | -$58.38M | -$1.91M | -$2.17M |